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  The	  aim	  of	  the	  present	  study	  was	  to	  reveal	  the	  characteristic	  features	  of	  genital	  
C.	   suis	   infection	   and	   re-­‐infection	   in	   sows	   by	   studying	   the	   immune	   response,	  pathological	   changes,	   replication	  of	  chlamydial	  bacteria	   in	   the	  genital	   tract	  and	  excretion	   of	   viable	   bacteria.	   Gilts	   were	   intravaginally	   infected	   and	   re-­‐infected	  with	  Chlamydia	  suis	  strain	  S45,	  the	  type	  strain	  of	  this	  species.	  We	  demonstrated	  that	   S45	   is	   pathogenic	   for	   the	   female	   urogenital	   tract.	   Chlamydia	   replication	  occurred	   throughout	   the	  urogenital	   tract,	   causing	   inflammation	   and	  pathology.	  Furthermore,	   genital	   infection	   elicited	   both	   cellular	   and	   humoral	   immune	  responses.	   Compared	   to	   the	   primo-­‐infection	   of	   gilts	   with	   Chlamydia	   suis,	   re-­‐infection	   was	   characterized	   by	   less	   severe	   macroscopic	   lesions	   and	   less	  
Chlamydia	   elementary	   bodies	   and	   inclusions	   in	   the	   urogenital	   tract.	   This	  indicates	   the	   development	   of	   a	   certain	   level	   of	   protection	   following	   the	   initial	  infection.	   Protective	   immunity	   against	   re-­‐infection	   associated	   with	   higher	  
Chlamydia-­‐specific	   IgG	   and	   IgA	   antibody	   titers	   in	   sera	   and	   vaginal	   secretions,	  higher	   proliferative	   responses	   of	   peripheral	   blood	   mononuclear	   cells	   (PBMC),	  higher	  percentages	  of	  blood	  B	  lymphocytes,	  monocytes	  and	  CD4-­‐CD8+	  T	  cells	  and	  upregulated	  production	  of	  IFN-­‐γ	  and	  IL-­‐10	  by	  PBMC.	  
